Search Results - "Jokar, Safura"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Functionalized mesoporous silica-coated magnetic graphene oxide by polyglycerol-g-polycaprolactone with pH-responsive behavior: Designed for targeted and controlled doxorubicin delivery by Pourjavadi, Ali, Tehrani, Zahra Mazaheri, Jokar, Safura

    “…In the present work a novel multifunctional drug nanocarrier was prepared. Polyglycerol-g-polycaprolactone was grafted on Mesoporous silica-coated magnetic…”
    Get full text
    Journal Article
  2. 2

    Targeting Caveolin-1 and Claudin-5 with AY9944, Improve Blood–Brain Barrier Permeability; Computational Simulation and Experimental Study by Gholami, Leila, Jokar, Safura, Fatahi, Yousef, Samandari, Hedayat, Hamzehalipour Almaki, Javad, Hosseini, Marjan, Parviz, Mohsen

    Published in Cellular and molecular neurobiology (01-05-2022)
    “…The current study aimed to determine the protective effect of AY9944 related to Caveolin-1 and Claudin-5 role in lipid raft, which can rescue the blood–brain…”
    Get full text
    Journal Article
  3. 3

    The Footprint of Exosomes in the Radiation-Induced Bystander Effects by Jokar, Safura, Marques, Inês A., Khazaei, Saeedeh, Martins-Marques, Tania, Girao, Henrique, Laranjo, Mafalda, Botelho, Maria Filomena

    Published in Bioengineering (Basel) (31-05-2022)
    “…Radiation therapy is widely used as the primary treatment option for several cancer types. However, radiation therapy is a nonspecific method and associated…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells by Behnammanesh, Hossein, Erfani, Mostafa, Hajiramezanali, Maliheh, Jokar, Safura, Geramifar, Parham, Sabzevari, Omid, Amini, Mohsen, Mazidi, Seyed Mohammad, Beiki, Davood

    “…Objective(s): Somatostatin receptor-positive neuroendocrine tumors have been targeted using various peptide analogs radiolabeled with therapeutic radionuclides…”
    Get full text
    Journal Article
  6. 6

    Chitosan based supramolecular polypseudorotaxane as a pH-responsive polymer and their hybridization with mesoporous silica-coated magnetic graphene oxide for triggered anticancer drug delivery by Pourjavadi, Ali, Mazaheri Tehrani, Zahra, Jokar, Safura

    Published in Polymer (Guilford) (12-10-2015)
    “…Chitosan based polyseudorotaxane was designed as a pH-responsive supramolecular polymeric shell around the mesoporous silica-coated magnetic graphene oxide…”
    Get full text
    Journal Article
  7. 7

    Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation by Jokar, Safura, Erfani, Mostafa, Bavi, Omid, Khazaei, Saeedeh, Sharifzadeh, Mohammad, Hajiramezanali, Malihe, Beiki, Davood, Shamloo, Amir

    Published in Bioorganic chemistry (01-09-2020)
    “…[Display omitted] •The molecular interactions of designed peptides against Aβ peptide were evaluated by the molecular docking.•Targeting peptide synthesis of…”
    Get full text
    Journal Article
  8. 8

    Recent Clinical Implications of FAPI: Imaging and Therapy by Kiani, Mahshid, Jokar, Safura, Hassanzadeh, Leila, Behnammanesh, Hossein, Bavi, Omid, Beiki, Davood, Assadi, Majid

    Published in Clinical nuclear medicine (01-11-2024)
    “…The fibroblast activation protein (FAP) is a biomarker that is selectively overexpressed on cancer-associated fibroblasts (CAFs) in various types of tumoral…”
    Get full text
    Journal Article
  9. 9

    RadioLabeling of the Mutant form of Anti-PlGF Nanobody by 99mTc-Tricarbonyl by Rezazadeh, Tahereh, Tabatabaee Bafroee, Akram Sadat, Shahhosseini, Soraya, Jokar, Safura, Hasanramezani, Abolfazl, Arezumand, Roghaye

    “…Background: Molecular imaging is a highly effective method for diagnosing cancer and evaluating treatment. A molecular tracer often consists of two segments: A…”
    Get full text
    Journal Article
  10. 10

    Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy by Jokar, Safura, Khazaei, Saeedeh, Behnammanesh, Hossein, Shamloo, Amir, Erfani, Mostafa, Beiki, Davood, Bavi, Omid

    Published in Biophysical reviews (01-12-2019)
    “…Alzheimer’s disease (AD) is an irreversible neurological disorder that progresses gradually and can cause severe cognitive and behavioral impairments. This…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies by Khazaei, Saeedeh, Varela-Calviño, Ruben, Rad-Malekshahi, Mazda, Quattrini, Federico, Jokar, Safura, Rezaei, Nima, Balalaie, Saeed, Haririan, Ismaeil, Csaba, Noemi, Garcia-Fuentes, Marcos

    Published in Drug delivery and translational research (01-02-2024)
    “…Integrating peptide epitopes in self-assembling materials is a successful strategy to obtain nanovaccines with high antigen density and improved efficacy. In…”
    Get full text
    Journal Article
  13. 13

    Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors by Behnammanesh, Hossein, Jokar, Safura, Erfani, Mostafa, Geramifar, Parham, Sabzevari, Omid, Amini, Mohsen, Mazidi, Seyed Mohammad, Hajiramezanali, Maliheh, Beiki, Davood

    Published in Bioorganic chemistry (01-01-2020)
    “…[Display omitted] •Peptide sequences were designed by molecular docking study.•Using the 3-Benzothienylalanyl in antagonist improves the receptor binding…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Design, preparation and biological evaluation of a 177 Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors by Behnammanesh, Hossein, Jokar, Safura, Erfani, Mostafa, Geramifar, Parham, Sabzevari, Omid, Amini, Mohsen, Mazidi, Seyed Mohammad, Hajiramezanali, Maliheh, Beiki, Davood

    Published in Bioorganic chemistry (01-01-2020)
    “…Somatostatin receptor-targeted radionuclide therapy has become an effective treatment in patients with neuroendocrine tumors. Recently, investigations on the…”
    Get full text
    Journal Article
  16. 16

    Design of a New 99m Tc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR 4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation by Hassanzadeh, Leila, Erfani, Mostafa, Jokar, Safura, Shariatpanahi, Marjan

    Published in Current radiopharmaceuticals (2024)
    “…C-X-C Chemokine receptor type 4 (CXCR4) is often overexpressed or overactivated in different types and stages of cancer disease. Therefore, it is considered a…”
    Get more information
    Journal Article